Emerging Net Income from 2010 to 2026
| EWPI Stock | USD 0.0001 0.00 0.00% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -369.3 K | Current Value -350.8 K | Quarterly Volatility 99.4 K |
Check Emerging World financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emerging World's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 80.1 K or Total Revenue of 0.0, as well as many indicators such as . Emerging financial statements analysis is a perfect complement when working with Emerging World Valuation or Volatility modules.
Emerging | Net Income | Build AI portfolio with Emerging Stock |
The Net Income trend for Emerging World Pharma offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Emerging World is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Emerging World's Net Income Growth Pattern
Below is the plot of the Net Income of Emerging World Pharma over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Emerging World Pharma financial statement analysis. It represents the amount of money remaining after all of Emerging World Pharma operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Emerging World's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Emerging World's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (410.32 K) | 10 Years Trend |
|
Net Income |
| Timeline |
Emerging Net Income Regression Statistics
| Arithmetic Mean | (380,282) | |
| Coefficient Of Variation | (26.13) | |
| Mean Deviation | 49,468 | |
| Median | (410,316) | |
| Standard Deviation | 99,382 | |
| Sample Variance | 9.9B | |
| Range | 410K | |
| R-Value | (0.31) | |
| Mean Square Error | 9.5B | |
| R-Squared | 0.1 | |
| Significance | 0.22 | |
| Slope | (6,170) | |
| Total Sum of Squares | 158B |
Emerging Net Income History
Other Fundumenentals of Emerging World Pharma
Emerging World Net Income component correlations
Click cells to compare fundamentals
About Emerging World Financial Statements
Investors use fundamental indicators, such as Emerging World's Net Income, to determine how well the company is positioned to perform in the future. Although Emerging World's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Emerging World Correlation against competitors. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Is there potential for Drug Manufacturers - Specialty & Generic market expansion? Will Emerging introduce new products? Factors like these will boost the valuation of Emerging World. Projected growth potential of Emerging fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Emerging World listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0) |
The market value of Emerging World Pharma is measured differently than its book value, which is the value of Emerging that is recorded on the company's balance sheet. Investors also form their own opinion of Emerging World's value that differs from its market value or its book value, called intrinsic value, which is Emerging World's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Emerging World's market value can be influenced by many factors that don't directly affect Emerging World's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Emerging World's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Emerging World should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Emerging World's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.